Blog articles

Unlocking the secrets of the genome
It was once believed that 99% of our genome was made up of ‘junk’ DNA with no purpose. Recent discoveries suggest this is far from the truth

Tuberculosis: genome sequencing and new treatment
TB cases are falling worldwide, but with hard-to-treat strains more prevalent than ever, how can genomics help? And what’s new on the treatment horizon?

Cancer immunotherapy: predicting outcomes
Today's monoclonal antibody treatments benefit some patients but can be harmful to others; the search for reliable predictive biomarkers is on

Genome editing: 5 key questions answered
News stories in biomedicine are being dominated by genome editing, Crispr and other methods. So what's it all about, and what might it mean for healthcare?

Molecular memories: is genomics key to a dementia cure?
Dementia is a major healthcare issue in ageing western societies. What do we know about the biological basis of memory that could combat this?

Fighting adverse drug reactions
When it comes to therapeutic treatments, one size doesn’t fit all. Could genomic tests be the key to minimising the harmful side effects of drugs?

Ethical editing: therapeutics and ‘enhancement’
A newly published report takes a different approach towards the controversial editing of human genomes

How genome editing could enter mainstream medicine
Forget designer babies and novelty pets. The potential for genome editing to improve the health of the general population is already emerging

Point-of-care testing in genomics
Rapid advances in technology are revolutionising healthcare. How viable is portable DNA testing?

‘Omic’ insights into Parkinson’s disease
Recent research reveals potential dawn of personalised medicine for neurological disorders might be more than just 'gut feeling'

Up close and personal for better breast cancer treatments
New project launched at Cancer Research Cambridge Institute helps to bring medicine based on DNA sequencing to the clinic

Looking good: genomic-based approaches in eye disease
Gene-based treatments for eye diseases advance in the battle against blindness and related life-threatening conditions